John T. Treace, Chief Executive Officer at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 329,406 shares at $20.74 ($7.1M) on 2021-10-22, disclosed to the SEC on 2021-10-22.
Open-market sale of $7.1M TMCI by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.79 | 22,612 | $561K | 7.9% |
| 2 | $24.79 | 22,612 | $561K | 7.9% |
| 3 | $25.37 | 8,215 | $208K | 2.9% |
| 4 | $25.37 | 8,215 | $208K | 2.9% |
| 5 | $19.89 | 34,325 | $683K | 9.6% |
| 6 | $19.89 | 34,325 |
| $683K |
| 9.6% |
| 7 | $20.67 | 26,701 | $552K | 7.8% |
| 8 | $20.67 | 26,701 | $552K | 7.8% |
| 9 | $21.49 | 2,768 | $59K | 0.8% |
| 10 | $21.49 | 2,768 | $59K | 0.8% |
| 11 | $23.07 | 8,207 | $189K | 2.7% |
| 12 | $23.07 | 8,207 | $189K | 2.7% |
| 13 | $23.86 | 4,044 | $96K | 1.4% |
| 14 | $23.86 | 4,044 | $96K | 1.4% |
| 15 | $24.50 | 39 | $956 | 0.0% |
| 16 | $20.74 | 57,534 | $1.2M | 16.8% |
| 17 | $20.74 | 57,534 | $1.2M | 16.8% |
| 18 | $21.16 | 555 | $12K | 0.2% |
| Total | $21.54 avg | 329,406 | $7.1M | 100% |
| Filing → |
| TMCI | BUY | 2026-06-11 | $211K | — | Filing → |
| TMCI | BUY | 2026-06-01 | $178K | — | Filing → |
| TMCI | BUY | 2026-05-28 | $341K | — | Filing → |